1月7日，在港股大盘回调之际，生物医药、创新药概念等医药板块延续近日上涨态势。成份股中，和黄医药（00013.HK）表现不俗，截至收盘，该股涨幅为5.45%，报22.46港元/股，成功录得5连涨。分析认为，和黄医药今日股价涨势靓丽，一方面得益于港股医药板块回暖拉动；另一方面则受公司当日发布的重磅利好公告刺激。1月7日，和黄医药发布公告显示，新型脾酪氨酸激酶（“Syk”）抑制剂索乐匹尼布，用于治疗温...
Source Link1月7日，在港股大盘回调之际，生物医药、创新药概念等医药板块延续近日上涨态势。成份股中，和黄医药（00013.HK）表现不俗，截至收盘，该股涨幅为5.45%，报22.46港元/股，成功录得5连涨。分析认为，和黄医药今日股价涨势靓丽，一方面得益于港股医药板块回暖拉动；另一方面则受公司当日发布的重磅利好公告刺激。1月7日，和黄医药发布公告显示，新型脾酪氨酸激酶（“Syk”）抑制剂索乐匹尼布，用于治疗温...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.